Top

Published in:

Open Access 01-05-2019 | Short Communication

Risk factor control and outpatient attendance in young adults with diabetes

Authors: F. Nadeem, A. Urwin, M. Marshall, I. Doughty, H. Thabit, M. K. Rutter, L. Leelarathna

Published in: Acta Diabetologica | Issue 5/2019

Excerpt

Diabetes is one of the commonest chronic medical conditions amongst those aged 18–25 years. Type 1 diabetes (T1DM) predominates in this age group, but, recently, the prevalence of type 2 diabetes (T2DM) has also increased in young adults. Young people experience various social, psychological, and physiological changes, often leading to poor glycaemic control and non-engagement with health services [1]. …

Lyons SK, Becker DJ, Helgeson VS (2014) Transfer from pediatric to adult health care: effects on diabetes outcomes. Pediatr Diabetes 15(1):10–17 (Epub 2013/12/20)CrossRef

The Diabetes Control and Complications Trial Research Group, Epidemiology of Diabetes Interventions Complications Research Group (2014) Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes. https://doi.org/10.2337/db14-0930CrossRef

Royal College Of Paediatrics and Child Health. National paediatric diabetes audit 2015–2016 Report 1: care processes and outcomes. 2015–2016. https://www.rcpch.ac.uk/resources/national-paediatric-diabetes-audit-npda-national-reports. Accessed 13 Dec 2018

McKnight JA, Wild SH, Lamb MJ et al (2015) Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med 32(8):1036–1050 (Epub 2014/12/17)CrossRef

Miller KM, Foster NC, Beck RW et al (2015) Current state of type 1 diabetes treatment in the US: updated data from the T1D exchange clinic registry. Diabetes Care 38(6):971–978 (Epub 2015/05/23)CrossRef

Title: Risk factor control and outpatient attendance in young adults with diabetes
Authors: F. Nadeem
A. Urwin
M. Marshall
I. Doughty
H. Thabit
M. K. Rutter
L. Leelarathna
Publication date: 01-05-2019
Publisher: Springer Milan
Published in: Acta Diabetologica / Issue 5/2019
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-018-1261-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Risk factor control and outpatient attendance in young adults with diabetes

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2019

The STOP DIABETES study: when prevention works

Our second genome and the impact on metabolic disorders: why gut microbiome is an important player in diabetes and associated abnormalities

Diagnosis of cardiovascular autonomic neuropathy in diabetes: as simple as possible, but not simpler? An answer

Genetic characterization of suspected MODY patients in Tunisia by targeted next-generation sequencing

Combination therapy of an iNKT cell ligand and CD40–CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients

Insulin pump settings and glucose patterns during a 1008-km non-stop bicycle race in a patient with type 1 diabetes mellitus

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page